Joshua Rabinowitz
Corporate Officer/Principal chez Princeton University
Profil
Dr. Joshua Rabinowitz is Co-Founder at Raze Therapeutics, Inc., a Member at Lewis-Sigler Institute For Integrative Genomics, a Member at The Cancer Institute of New Jersey and a Professor at Princeton University.
He received his undergraduate degree from the University of North Carolina at Chapel Hill and a doctorate degree from Stanford University.
Postes actifs de Joshua Rabinowitz
Sociétés | Poste | Début |
---|---|---|
Princeton University | Corporate Officer/Principal | - |
The Cancer Institute of New Jersey
The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ. | Corporate Officer/Principal | - |
Lewis-Sigler Institute For Integrative Genomics | Corporate Officer/Principal | - |
Anciens postes connus de Joshua Rabinowitz
Sociétés | Poste | Fin |
---|---|---|
Raze Therapeutics, Inc.
Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Fondateur | - |
Formation de Joshua Rabinowitz
The University of North Carolina at Charlotte | Undergraduate Degree |
Stanford University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
Raze Therapeutics, Inc.
Raze Therapeutics, Inc. BiotechnologyHealth Technology Raze Therapeutics, Inc. engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across solid and hematologic cancers, including genetically-defined cancers. The company was founded by Vamsi Mootha, Joshua Rabinowitz, David Sabatini, and Adam Friedman on August 8, 2014 and is headquartered in Cambridge, MA. | Health Technology |
The Cancer Institute of New Jersey
The Cancer Institute of New Jersey Hospital/Nursing ManagementHealth Services The Cancer Institute of New Jersey operates as a cancer centre. The firm offers cancer care for adults and children, providing access to the medicines and treatment options. It also offers clinical, patient education resources and support services. The company was founded in and is headquartered in New Brunswick, NJ. | Health Services |
Lewis-Sigler Institute For Integrative Genomics |